These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12604683)

  • 1. Modification of noradrenaline release in pithed spontaneously hypertensive rats by I1-binding sites in addition to alpha2-adrenoceptors.
    Raasch W; Jungbluth B; Schäfer U; Häuser W; Dominiak P
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1063-71. PubMed ID: 12604683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norepinephrine release is reduced by I(1)-receptors in addition to alpha(2)-adrenoceptors.
    Raasch W; Jungbluth B; Schäfer U; Häuser W; Dominiak P
    Ann N Y Acad Sci; 2003 Dec; 1009():270-3. PubMed ID: 15028598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine.
    Bock C; Niederhoffer N; Szabo B
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):262-71. PubMed ID: 10344524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that some imidazoline derivatives inhibit peripherally the vasopressor sympathetic outflow in pithed rats.
    Monroy-Ordoñez EB; Villalón CM; Cobos-Puc LE; Márquez-Conde JA; Sánchez-López A; Centurión D
    Auton Neurosci; 2008 Dec; 143(1-2):40-5. PubMed ID: 18774761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presynaptic effects of moxonidine in isolated buffer perfused rat hearts: role of imidazoline-1 receptors and alpha2-adrenoceptors.
    Schäfer U; Burgdorf C; Engelhardt A; Kurz T; Richardt G
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1163-70. PubMed ID: 12438540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of the inhibition by moxonidine and agmatine on the cardioaccelerator sympathetic outflow in pithed rats.
    Cobos-Puc LE; Villalón CM; Ramírez-Rosas MB; Sánchez-López A; Lozano-Cuenca J; Gómez-Díaz B; MaassenVanDenBrink A; Centurión D
    Eur J Pharmacol; 2009 Aug; 616(1-3):175-82. PubMed ID: 19527708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agmatine, an endogenous ligand at imidazoline binding sites, does not antagonize the clonidine-mediated blood pressure reaction.
    Raasch W; Schäfer U; Qadri F; Dominiak P
    Br J Pharmacol; 2002 Feb; 135(3):663-72. PubMed ID: 11834614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interruption of central neuronal pathway of imidazoline I1 receptor mediates the hypertensive effect of cyclosporine in rats.
    El-Mas MM; Omar AG; Helmy MM; Mohy El-Din MM
    Brain Res; 2009 Jan; 1248():96-106. PubMed ID: 19028461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
    Moreira TS; Takakura AC; Menani JV; Colombari E
    Eur J Pharmacol; 2007 Jun; 563(1-3):164-71. PubMed ID: 17382316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of I(1)-imidazoline and alpha(2)-adrenergic receptors in the modulation of glucose metabolism in the spontaneously hypertensive obese rat model of metabolic syndrome X.
    Velliquette RA; Ernsberger P
    J Pharmacol Exp Ther; 2003 Aug; 306(2):646-57. PubMed ID: 12756274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of presynaptic imidazoline receptors in the alpha 2-adrenoceptor-independent inhibition of noradrenaline release by imidazoline derivatives.
    Göthert M; Molderings GJ
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar; 343(3):271-82. PubMed ID: 1678140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological analysis of the cardiac sympatho-inhibitory actions of moxonidine and agmatine in pithed spontaneously hypertensive rats.
    Cobos-Puc LE; Sánchez-López A; Centurión D
    Eur J Pharmacol; 2016 Nov; 791():25-36. PubMed ID: 27565220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moxonidine: a new antiadrenergic antihypertensive agent.
    Prichard BN; Graham BR; Owens CW
    J Hypertens Suppl; 1999 Aug; 17(3):S41-54. PubMed ID: 10489098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of locus coeruleus neurons by non-I1/I2-type imidazoline receptors: an in vivo and in vitro electrophysiological study.
    Ugedo L; Pineda J; Ruiz-Ortega JA; Martín-Ruiz R
    Br J Pharmacol; 1998 Dec; 125(8):1685-94. PubMed ID: 9886760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commissural nucleus of the solitary tract regulates the antihypertensive effects elicited by moxonidine.
    Totola LT; Alves TB; Takakura AC; Ferreira-Neto HC; Antunes VR; Menani JV; Colombari E; Moreira TS
    Neuroscience; 2013 Oct; 250():80-91. PubMed ID: 23850502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN; Owens CW; Graham BR
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
    Mukaddam-Daher S; Menaouar A; Gutkowska J
    Eur J Pharmacol; 2006 Jul; 541(1-2):73-9. PubMed ID: 16774751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of pertussis toxin-sensitive and -insensitive mechanisms in alpha-adrenoceptor modulation of noradrenaline release from rat sympathetic neurones in tissue culture.
    Hill CE; Powis DA; Hendry IA
    Br J Pharmacol; 1993 Sep; 110(1):281-8. PubMed ID: 8106104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of alpha-2 adrenoceptors in the effects of moxonidine on intestinal motility and fluid transport.
    Liu L; Coupar IM
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1367-74. PubMed ID: 9400012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual effect of agmatine in the bisected rat vas deferens.
    Santos WC; Smaili SS; Jurkiewicz A; Piçarro I; Garcez-do-Carmo L
    J Pharm Pharmacol; 2003 Mar; 55(3):373-80. PubMed ID: 12724044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.